GlaxoSmithKline investigating bribery of foreign doctors

GSK allegedly offered doctors flexible travel arrangements and free samples that were later flipped for money

Just ask Hewlett-Packard, Alcoa and Avon — the U.S. government is taking foreign bribery seriously in 2014. Now, pharmaceutical giant GlaxoSmithKline (GSK) could be the next to feel the bribery sting.

The company announced on April 16 that it is investigating claims into possible bribery of foreign doctors in Jordan and Lebanon. The Wall Street Journal reports that GSK offered these doctors flexible travel arrangements and free samples that were later flipped for money.

Assistant Editor

author image

Zach Warren

Zach Warren is Assistant Editor of InsideCounsel magazine, where he oversees online content submissions and administers InsideCounsel's enewsletters. Zach specializes in new media and multimedia...

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.